HIGHLINE WEALTH PARTNERS LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2042654
SHERMAN OAKS, CA
Position in ALNY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$5,418
+$125 QoQ
Shares Held
18
+12.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#707
of 784 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $984,033 across 14 Biotechnology names. ALNY ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,739 | $863,813 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
1,000 | $54,540 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20 | $12,470 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
48 | $11,566 | |
| 5 | EXEL |
Exelixis, Inc.
|
201 | $10,936 | |
| 6 | TECH |
BIO-TECHNE Corp
|
128 | $9,043 | |
| 7 | INCY |
Incyte Corp
|
65 | $7,368 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
18 | $5,418 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,418 | 18 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $5,293 | 16 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $3,181 | 8 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $3,648 | 8 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2,282 | 7 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,080 | 4 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $705 | 3 | Shares | Sole | 2025-01-10 | |
| No filing history on record for this holder in this stock. | ||||||